WuXi Firms Surge on Slimmer Chances of US Biosecure Passage
WuXi AppTec Co. and WuXi Biologics Cayman Inc., two Chinese biotech service providers, saw their stock jump Monday after a draft US bill that would have eliminated their pivotal position in worldwide drug research lost its final significant window for enactment this year. Early Monday trading in Hong Kong saw a 12% increase in WuXi…